Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VC005 in Moderate to Severe Atopic Dermatitis
NCT06723080Phase 3Recruiting
- Sponsor
- Jiangsu Vcare PharmaTech Co., Ltd.
- Start
- Dec 2024
- Primary completion
- Aug 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of VC-005 in atopic dermatitis (AD), sponsored by Jiangsu Vcare PharmaTech Co., Ltd.. Started Dec 2024; status: recruiting.
02
Drugs
VC-005
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT06723080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06723080.